Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04206215 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jul 2, 2026 → Jul 2, 2027
See other at-risk trials from Spaulding Rehabilitation Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 2, 2026 to Jul 2, 2027
    • Study completion pushed from Feb 28, 2027 to Dec 28, 2027
    v12
  2. Primary completion date: Oct 6, 2025 to Jul 2, 2026
    • Study completion date: Jan 5, 2026 to Feb 28, 2027
    v11
  3. Primary completion date: Oct 6, 2024 to Oct 6, 2025
    • Study completion date: Jan 5, 2025 to Jan 5, 2026
    v10
  4. Primary completion date: May 15, 2024 to Oct 6, 2024
    • Study completion date: Jul 15, 2024 to Jan 5, 2025
    v9
  5. Primary completion date: May 15, 2022 to May 15, 2024
    • Study completion date: Jul 15, 2022 to Jul 15, 2024
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Lead sponsor: [Redacted] to Spaulding Rehabilitation Hospitalv7 Show 8 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: May 15, 2022
    • Study completion date: Jul 15, 2022
    • Start date: Apr 16, 2021
    • Site details revised
    • Eligibility criteria shortened, about 5 words
    • Collaborators expanded, about 3 words
    • Study title shortened, about 5 words
  2. Re-verified, no change to tracked fieldsv6
  3. Lead sponsor: Spaulding Rehabilitation Hospital to [Redacted]v5 Show 6 more changesShow less
    • Trial status: Not Yet Recruiting to Withheld
    • Primary completion date: Dec 2021 to not stated
    • Study completion date: Mar 2022 to not stated
    • Start date: Mar 2021 to not stated
    • Collaborators shortened, about 3 words
    • Study title expanded, about 5 words
  4. Primary completion date: Feb 2021 to Dec 2021
    • Start date: Nov 2020 to Mar 2021
    • Study completion date: Jun 2021 to Mar 2022
    v4
  5. Start date: Jun 2020 to Nov 2020v3
  6. Start date: Dec 2019 to Jun 2020
    • Secondary endpoints: details revised at 3 of 19 entries
    • Site contact updated
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
Trial Details
NCT Number NCT04206215
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: Highland Instruments, Inc.
Conditions
(from sponsor)		 Chronic Pain, Carpal Tunnel Syndrome
Related terms Carpal Tunnel Syndrome, Chronic Pain
Enrollment 95 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov